$GYRE

$6.51 +$0.44 (7.17%) Live

$GYRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 111.5M shares outstanding

Who owns GYRE?

By type of holder

Institutions 7.8% Insiders 5.5% Everyone else 86.8%

Concentration Top 10 holders own 100.4%

GNI Group Ltd. 77.4% · Ying Luo 9.2%

Institutional ownership

7.8%

+4.7 pts vs last qtr

Institutional holders

+3 vs last qtr

Net shares bought

+5.3M

by institutions in Q2 2026

New / sold out

11 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

HSG Holding Ltd NEW +3.8M
Octagon Capital Advisors LP NEW +954.4K

Biggest sellers in Q2 2026

Vanguard Capital Management LLC −107.3K
Brevan Howard Capital Management LP SOLD OUT −13.8K

Who is planning to sell?

Notices of proposed sale, last 12 months

$6.69M

2 notices from 1 person

Shares covered

848.0K

0.76% of the company

Arranged in advance

68%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Ye Weiguo Officer $6.69M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+36.3%

+10.88% a year

Each share's claim on the business

−26.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $28.6M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years44% Under 1 year56%

Quarterly turnover

81.2%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting GYRE on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
HH HSG Holding Ltd	3.8M	3.36%	NEW	Q2 '26	2.1%
Shares held by quarter Peak holding3.8M (Q2'26) Change over 8 quarters+3.8M Share of the company3.360% HSG Holding Ltd's full portfolio →
B BlackRock, Inc.	993.9K	0.89%	+235.3K (+31.0%)	2023	0.0%
Shares held by quarter Peak holding993.9K (Q2'26) Change over 8 quarters+479.5K Share of the company0.890% BlackRock, Inc.'s full portfolio →

HSG Holding Ltd

3.8M

% of company

3.36%

Change vs last qtr

NEW

Held since

Q2 '26

BlackRock, Inc.

993.9K

% of company

0.89%

Change vs last qtr

+235.3K (+31.0%)

Held since

2023

28 more super investors behind a free account

See every manager holding Gyre Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting GYRE on Form N-PORT; together they hold 2.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.05M	614.7K	0.55%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$2.6M	394.3K	0.35%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.05M

% of company

0.55%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$2.6M

% of company

0.35%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Gyre Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GG GNI Group Ltd. 5%+ holder 13D · 69.1%	86.3M	77.41%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company77.410% Disclosed stake13D · 69.1% View the 13D/G filing →
YL Ying Luo 5%+ holder 13D · 8.6%	10.2M	9.16%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company9.160% Disclosed stake13D · 8.6% View the 13D/G filing →

GNI Group Ltd.

5%+ holder13D · 69.1%

86.3M

% of company

77.41%

Change vs last qtr

—

Held since

—

Ying Luo

5%+ holder13D · 8.6%

10.2M

% of company

9.16%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of Gyre Therapeutics, Inc..

Comments